Chapter 23: Antiseizure Agents

Epilepsy represents a collection of various neurological syndromes characterized by seizures, which result from the sudden, excessive discharge of electrical energy from nerve cells within the brain, sometimes causing convulsions. Seizures are broadly classified into two main categories: generalized seizures, which originate in one area and quickly spread across both cerebral hemispheres, including dangerous types like tonic-clonic seizures (formerly grand mal), absence seizures (formerly petit mal), and status epilepticus; and partial seizures, also known as focal seizures, which remain limited to one specific brain region and can be simple or complex. The therapeutic goal of antiseizure (antiepileptic) drugs is to stabilize hyperactive nerve membranes, either by blocking ionic channels in the cell membrane or by enhancing the effects of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Major drug classes for generalized seizures include Hydantoins, such as phenytoin, often chosen for being less sedating but requiring close monitoring for severe effects like gingival hyperplasia; Barbiturates (e.g., phenobarbital), which depress the central nervous system (CNS) by inhibiting the ascending reticular activating system (RAS); and Benzodiazepines (e.g., diazepam), which potentiate GABA. Succinimides, specifically ethosuximide, are predominantly used for absence seizures. Other agents like valproic acid may also modulate GABA activity. Drugs for partial seizures, such as carbamazepine, gabapentin, lamotrigine, and oxcarbazepine, stabilize membranes through various distinct mechanisms. A primary concern across all antiseizure treatments is CNS depression, leading to common adverse effects like drowsiness, fatigue, confusion, and dizziness. Nursing care for patients receiving these agents requires comprehensive assessment, monitoring for potential toxicities like bone marrow suppression or severe dermatological reactions (e.g., Stevens-Johnson syndrome), ensuring slow withdrawal of the medication to prevent seizure rebound, and addressing lifestyle impacts such as restrictions on driving. Furthermore, special consideration must be given to patients across the lifespan, noting that children often metabolize drugs quickly, and certain ethnic groups, like Arab Americans and Asian Americans, may require lower doses due to altered liver enzyme function. Women of childbearing age must receive extensive counseling regarding the significant risks of fetal abnormalities associated with many of these drugs.